{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:27:40Z","timestamp":1787671660261,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.maturitas.2009.09.011","type":"journal-article","created":{"date-parts":[[2009,10,10]],"date-time":"2009-10-10T05:10:26Z","timestamp":1255151426000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate"],"prefix":"10.1016","volume":"64","author":[{"given":"Manuel","family":"Mu\u00f1oz-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Reyes-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mezquita-Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan de","family":"Dios Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Estrella","family":"Ruiz-Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Escobar-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2009.09.011_bib1","doi-asserted-by":"crossref","first-page":"32347","DOI":"10.1074\/jbc.273.48.32347","article-title":"The collagenolytic activity of cathepsin K is unique among mammalian proteinases","volume":"273","author":"Garnero","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.maturitas.2009.09.011_bib2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.2001.16.10.1747","article-title":"Cathepsin K, osteoclastic resorption, and osteoporosis therapy","volume":"16","author":"Zaidi","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2009.09.011_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2006.07.015","article-title":"A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys","volume":"40","author":"Kumar","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2009.09.011_bib4","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","article-title":"Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis","volume":"89","author":"Fratzl-Zelman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2009.09.011_bib5","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.maturitas.2009.09.011_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00198-006-0286-8","article-title":"Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases","volume":"18","author":"Henriksen","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2009.09.011_bib7","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2009.09.011_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2009.09.011_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ncpendmet0121","article-title":"Drug insight: bisphosphonates for postmenopausal osteoporosis","volume":"2","author":"Chapurlat","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2009.09.011_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bone.2006.02.060","article-title":"Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts\/osteocytes with novel analogs","volume":"39","author":"Plotkin","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2009.09.011_bib11","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2009.09.011_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.exger.2005.04.001","article-title":"Serum levels of cathepsin K decrease with age in both women and men","volume":"40","author":"Kerschan-Schindl","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.maturitas.2009.09.011_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lab.2005.03.016","article-title":"Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?","volume":"146","author":"Holzer","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.maturitas.2009.09.011_bib14","first-page":"1","article-title":"Serum cathepsin K reflects osteclastic activity in women with postmenopausal osteoporosis and patients with Pagets disease","volume":"52","author":"Meier","year":"2006","journal-title":"Clin Lab"},{"issue":"Suppl 3","key":"10.1016\/j.maturitas.2009.09.011_bib15","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00198-002-1348-1","article-title":"Assessment of prevalent and incident vertebral fractures in osteoporosis research","volume":"14","author":"Genant","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2009.09.011_bib16","first-page":"97","article-title":"Biochemical markers of bone turnover: part I: Biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.maturitas.2009.09.011_bib17","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1359\/JBMR.050403","article-title":"Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover","volume":"20","author":"Nenonen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2009.09.011_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S8756-3282(00)00248-9","article-title":"Serum crosslaps for monitoring the response in individuals undergoing antiresorptive therapy","volume":"26","author":"Christgau","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2009.09.011_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1346.020","article-title":"Molecular mechanism of the life and death of the osteoclast","volume":"1068","author":"Tanaka","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.maturitas.2009.09.011_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0272-6386(03)00203-8","article-title":"Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis","volume":"41","author":"Chu","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.maturitas.2009.09.011_bib21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/clinchem\/46.11.1751","article-title":"Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium","volume":"46","author":"Alatalo","year":"2000","journal-title":"Clin Chem"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512209003259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512209003259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:46:57Z","timestamp":1759913217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512209003259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0378512209003259"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2009.09.011","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2009.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}